Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05323084 · ClinicalTrials.gov registry record · NA

Effect of a Dietary Supplement on Quality of Life

A NA study, sponsored by Pennington Biomedical Research Center.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT05323084: Completed NA study, sponsored by Pennington Biomedical Research Center.

NCT05323084 is a NA study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05323084, a NA study, has completed, sponsored by Pennington Biomedical Research Center.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The purpose of this research study is to evaluate the effect of a combination of 3 food components to improve the quality of life in people who have trouble sleeping. Ten subjects with insomnia will drink 2 ounces of the supplement or a placebo for 1 week and after a 2 weeks washout period, will take the treatment they did not take the first week. Questionnaires to evaluate quality of life, and a sleep study will be done before and after each treatment week.

Primary Outcome

Total score ranges from 20 to 140 with higher scores being better quality of life

Interventions

  • DIETARY_SUPPLEMENT Dietary supplement

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2022-02-25
Est. Completion 2022-09-07
Phase NA

What the finished NCT05323084 record still lists

NCT05323084 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Dietary supplement is the first listed.

NCT05323084 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05323084 about?

NCT05323084 is a clinical study titled "Effect of a Dietary Supplement on Quality of Life". The purpose of this research study is to evaluate the effect of a combination of 3 food components to improve the quality of life in people who have trouble sleeping. Ten subjects with insomnia will drink 2 ounces of the supplement or a placebo for 1 week and after a 2 weeks washout period, will tak...

What is the current status of trial NCT05323084?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2022-02-25. Estimated completion is 2022-09-07.

What interventions are being tested in trial NCT05323084?

The interventions under investigation include: Dietary supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05323084?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05323084's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05323084, the US trial registry maintained by the National Library of Medicine. NCT05323084 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.